Latest Period
Q1 2026
Security Snapshot
Sanofi - Common Stock and American Depositary Receipts (SNY) Institutional Ownership
CUSIP: 80105N105
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
735
Shares (Excl. Options)
209,730,611
Price
$48.18
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock and American Depositary Receipts
- Symbol
- SNY on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 209,730,611
- Total 13F value
- $10,092,356,032
- Portfolio coverage rank
- 0.01%
- Share change
- -12,336,163
- Value change
- -$602,481,950
- Number of holders
- 735
- Shares outstanding
- 1,227,820,098
- SEC-reported price per share
- $42.50
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SNY - Sanofi - Common Stock and American Depositary Receipts is tracked under CUSIP 80105N105.
- 735 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 749 to 735 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $10,800,759,017 to $10,092,356,032.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 735 institutions filings for Q1 2026.
Security key
80105N105
Latest holder period
Q1 2026
13F holders
735
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
SNY full holder history
Sanofi SEC filings
Sanofi company facts
Sanofi 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 80105N105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
SNY
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Amundi | 5.1% | -2% | $3,034,811,531 | -$55,981,648 | 62,741,607 | -1.8% | AMUNDI | 31 Dec 2025 |
As of 31 Mar 2026, 735 institutional investors reported holding 209,730,611 shares of Sanofi - Common Stock and American Depositary Receipts (SNY). This represents 17% of the company’s total 1,227,820,098 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
12%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Dodge & Cox | 2.4% | 29,504,632 | -48% | 0.78% | $1,421,533,170 |
| MORGAN STANLEY | 1% | 12,511,867 | +37% | 0.04% | $602,821,892 |
| Fisher Asset Management, LLC | 0.93% | 11,442,163 | -5.8% | 0.19% | $551,283,461 |
| BANK OF AMERICA CORP /DE/ | 0.77% | 9,484,350 | +11% | 0.03% | $456,955,985 |
| FRANKLIN RESOURCES INC | 0.58% | 7,165,193 | +40% | 0.08% | $345,219,004 |
| Invesco Ltd. | 0.54% | 6,621,539 | +8.4% | 0.05% | $319,025,753 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | 0.48% | 5,887,466 | -16% | 0.93% | $283,658,112 |
| JPMORGAN CHASE & CO | 0.46% | 5,600,731 | +86% | 0.02% | $261,666,211 |
| Mondrian Investment Partners LTD | 0.41% | 5,040,065 | +12% | 4.2% | $242,830,335 |
| FEDERATED HERMES, INC. | 0.39% | 4,754,359 | +31% | 0.37% | $229,065,017 |
| FMR LLC | 0.33% | 4,010,161 | +18% | 0.01% | $193,209,547 |
| ENVESTNET ASSET MANAGEMENT INC | 0.31% | 3,861,894 | +21% | 0.05% | $186,066,032 |
| RAYMOND JAMES FINANCIAL INC | 0.31% | 3,812,745 | +16% | 0.06% | $183,681,946 |
| BRANDES INVESTMENT PARTNERS, LP | 0.3% | 3,723,100 | +28% | 1.3% | $179,380,074 |
| Boston Partners | 0.29% | 3,599,284 | -0.97% | 0.18% | $173,401,768 |
| MILLENNIUM MANAGEMENT LLC | 0.28% | 3,440,654 | +2410% | 0.12% | $165,770,710 |
| WELLS FARGO & COMPANY/MN | 0.28% | 3,415,115 | +25% | 0.03% | $164,540,197 |
| BlackRock, Inc. | 0.26% | 3,183,600 | -40% | 0% | $153,385,870 |
| ROYAL BANK OF CANADA | 0.26% | 3,155,080 | +18% | 0.03% | $152,011,000 |
| EQUITY INVESTMENT CORP | 0.22% | 2,663,054 | +1.5% | 2.5% | $128,305,962 |
| GOLDMAN SACHS GROUP INC | 0.21% | 2,582,456 | +31% | 0.02% | $124,422,725 |
| Regal Partners Ltd | 0.21% | 2,545,432 | +33% | 6.7% | $122,638,914 |
| BARCLAYS PLC | 0.19% | 2,356,559 | +10% | 0.04% | $113,539,013 |
| Alyeska Investment Group, L.P. | 0.19% | 2,306,229 | 0.31% | $111,114,113 | |
| NORTHERN TRUST CORP | 0.19% | 2,277,939 | +2.3% | 0.01% | $109,751,101 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 209,730,611 | $10,092,356,032 | -$602,481,950 | $48.18 | 735 |
| 2025 Q4 | 222,867,576 | $10,800,759,017 | -$672,105,364 | $48.46 | 749 |
| 2025 Q3 | 237,675,325 | $11,218,422,671 | -$539,935,504 | $47.20 | 702 |
| 2025 Q2 | 244,532,481 | $11,812,873,118 | -$577,758,150 | $48.31 | 717 |
| 2025 Q1 | 259,741,454 | $14,403,933,993 | -$180,220,976 | $55.46 | 757 |
| 2024 Q4 | 264,228,568 | $12,767,462,065 | -$860,043,070 | $48.23 | 720 |
| 2024 Q3 | 281,437,276 | $16,222,731,951 | +$599,910,816 | $57.63 | 744 |
| 2024 Q2 | 271,128,567 | $13,168,013,404 | +$734,828,511 | $48.52 | 712 |
| 2024 Q1 | 256,520,993 | $12,465,528,859 | +$459,383,443 | $48.60 | 698 |
| 2023 Q4 | 247,194,308 | $12,294,763,036 | -$268,613,679 | $49.73 | 698 |
| 2023 Q3 | 251,752,026 | $13,498,268,433 | -$168,648,433 | $53.64 | 687 |
| 2023 Q2 | 254,140,019 | $13,695,080,217 | -$662,761,362 | $53.90 | 664 |
| 2023 Q1 | 263,991,705 | $14,365,235,158 | +$295,714,571 | $54.42 | 662 |
| 2022 Q4 | 261,245,630 | $12,652,591,879 | +$345,396,940 | $48.43 | 630 |
| 2022 Q3 | 254,419,132 | $9,679,406,899 | -$220,838,009 | $38.02 | 562 |
| 2022 Q2 | 258,121,644 | $12,915,929,131 | +$532,423,962 | $50.03 | 637 |
| 2022 Q1 | 251,526,218 | $12,914,867,229 | +$355,652,280 | $51.34 | 610 |
| 2021 Q4 | 244,191,155 | $12,234,368,681 | +$342,381,878 | $50.10 | 612 |
| 2021 Q3 | 236,248,213 | $11,390,183,250 | +$1,641,499,675 | $48.21 | 572 |
| 2021 Q2 | 202,238,449 | $10,649,575,635 | +$297,631,632 | $52.66 | 579 |
| 2021 Q1 | 196,660,583 | $9,730,710,157 | +$1,139,121,574 | $49.46 | 565 |
| 2020 Q4 | 174,769,250 | $8,491,830,029 | +$61,794,877 | $48.59 | 595 |
| 2020 Q3 | 173,172,484 | $8,683,724,393 | -$298,357,223 | $50.17 | 566 |
| 2020 Q2 | 179,099,760 | $9,144,094,351 | -$395,321,354 | $51.05 | 575 |
| 2020 Q1 | 186,717,895 | $8,166,009,933 | +$342,858,039 | $43.72 | 539 |